Xeloda, Capecitabine News

22, 2013. These findings were presented by Jos Baselga, M.D., Ph.D., physician-in-chief at Memorial Sloan-Kettering Cancer Center in New York, N.Y., at the AACR Annual Meeting 2013, held in Washington, D.C., April 6-10. "EMILIA was a landmark phase III clinical trial," said Baselga.

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

Please enter my FDA Drug Approval Contest . It's a ton of fun. The more entries I get, the more data I have to crunch about sentiment for upcoming drug approvals that I can share with you.

Genentech, a member of the Roche Group , today announced that the U.S. Food and Drug Administration has approved Kadcyla for the treatment of people with HER2-positive metastatic breast cancer who have received prior treatment with Herceptin and a taxane chemotherapy.

CAMBRIDGE, Mass. & LAUSANNE, Switzerland -- -- ARIAD Pharmaceuticals, Inc. today announced the appointment of Jonathan E. Dickinson to the position of General Manager, ARIAD Pharmaceuticals , Sarl.